To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04522323
Title A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA | ESP | AUS

Facility Status City State Zip Country Details
Research Site Washington District of Columbia 20007 United States Details
Research Site Fort Myers Florida 33908 United States Details
Research Site Saint Louis Missouri 63156 United States Details
Research Site New York New York 10065 United States Details
Research Site Cleveland Ohio 44195 United States Details
Research Site Hershey Pennsylvania 17033 United States Details
Research Site Nashville Tennessee 37232 United States Details
Research Site Frankston 3199 Australia Details
Research Site Waratah 2298 Australia Details
Research Site Villejuif Cedex 94805 France Details
Research Site Barcelona 08003 Spain Details
Research Site Barcelona 08025 Spain Details
Research Site Barcelona 08035 Spain Details
Research Site Barcelona 08908 Spain Details
Research Site Córdoba 14004 Spain Details
Research Site Madrid 28040 Spain Details
Research Site Madrid 28041 Spain Details
Research Site Sabadell 08208 Spain Details
Research Site Sevilla 41013 Spain Details
Research Site Valencia 46009 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field